Hims and Hers Health's compounded Wegovy pill offering fuels market jitters

Feb 5 (Reuters) - Hims & Hers said it would begin offering compounded versions of Novo Nordisk's Wegovy pill at an introductory price of $49 per month. The company said the offering would be guided by clinical recommendations for personalized treatment, mirroring the approach it had taken with compounded injectable weight-loss drugs. Shares ​of Novo and rival Eli Lilly dropped after the launch announcement over concerns on how companies will protect margins as lower-cost alternatives emerge. Below are ...